NCT02186132View on ClinicalTrials.gov

0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
BradycardiaNeostigmine Adverse ReactionAdverse Reaction to Belladonna or Atropine
Interventions
DRUG

Atropine 0.6 mg

Atropine 0.6 mg intravenous

DRUG

Atropine 1.2 mg

Atropine 1.2 mg intravenous

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02186132 - 0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant | Biotech Hunter | Biotech Hunter